Asset
PL-8177
Palatin Technologies Inc. Common Stock
Revenue
No revenue reported in loaded filings.
Clinical trials (1)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT05466890 | phase2 | active_not_recruiting | 2022-09-15 | 2025-02-10 | Palatin Technologies, Inc | Phase 2a to Evaluate PL-8177 in Subjects with Active Ulcerative Colitis (UC) |
FDA applications (0)
This company has no applications containing this asset.